Case Number 4669
Request Date 16/03/2016
Completion Date 11/04/2016 

 

Details of the Request

Number of patients with an annual review in the last 12 months and number of patients with an MRI in the last 12 months being treated with the following products:

  • Tysabri
  • Gilenya
  • Interferon beta 1a
  • Interferon beta 1b
  • Copaxone
  • Lemtrada
  • Tecfidera
  • Aubagio
  • Plegridy

 

I would also like to request the following information on patient numbers:

  • Number of new MS diagnoses
  • Number of patients who have had a relapse in the above month
  • Number of relapse events in the above month

 

I would like this information for the period March 2015 to February 2016, broken down by month.

 

Details of the Response

1. Number of patients with an annual review in the last 12 months and number of patients with an MRI in the last 12 months being treated with the following products:

Please note: using the dates we have issued medicine to each patient as the ‘number of patients treated per month’ and made the assumption that essentially 100% of patients receive an annual review – otherwise we would have suspended their funding (this has not happened).

 

2. I would also like to request the following information on patient numbers:

Sent to requester.